Even though the exact cause of pulmonary arterial hypertension (PAH) is still unknown and there is no cure, the last decade has seen significant advances in the understanding of the pathophysiology of PAH, transforming the prognosis for PAH patients from symptomatic improvements in exercise tolerance 10 years ago, to delayed disease progression today.
Explore these developments and more in PAH Perspectives, which features clinical perspective and data to inform healthcare professionals caring for PAH patients.
©2020 Actelion Pharmaceuticals US, Inc. All rights reserved. cp-139253v3 1220
You need to be logged in to save this episode to a playlist.